Evaluation of the serum matrix metalloproteinase-9 as a biomarker for monitoring disease progression in Duchenne muscular dystrophy

Neuromuscul Disord. 2015 May;25(5):444-6. doi: 10.1016/j.nmd.2015.01.010. Epub 2015 Feb 2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Disease Progression*
  • Female
  • Humans
  • Male
  • Matrix Metalloproteinase 9 / blood*
  • Muscular Dystrophy, Duchenne / blood*
  • Muscular Dystrophy, Duchenne / physiopathology*

Substances

  • Matrix Metalloproteinase 9